Latest News and Press Releases

Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for more than 2½ yearsFDA requires drug to show long-term...

NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Glimpact, the first platform for analyzing the overall systemic environmental impact of products and organizations, released today their holiday ad...

YPrime earns prestigious EcoVadis rating, reinforcing commitment to sustainable clinical research.

The Turin’s technical University expands connections and networks with Ethiopia in line with its internationalization strategy, in which Africa is among the leading countries TURIN, Italy, March ...

NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...

Davos, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) --CEOs of established enterprises (10 years and up) sense internal paralysis despite owning richer historical data sets while emerging ‘digital...

Thought Leadership Initiative will Investigate How Prepared and Primed Organizations are to Unlock GenAI’s Next-Generation Business Value

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...

WOODLAND HILLS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for...

Phoenix, AZ, Oct. 14, 2024 (GLOBE NEWSWIRE) -- A recent paper by Shearston et al.,” Tampons as a source of exposure to metal(loid)s,” revealed their testing had detected trace amounts of 16 metals...